Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLIOBLASTOMA MULTIFORME”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06757153
What this trial is testing

Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients

Who this might be right for
Glioblastoma (GBM)
Zhongnan Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT05843253
What this trial is testing

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic Astrocytoma+7 more
Nationwide Children's Hospital 120
Not applicableStudy completedNCT01135875
What this trial is testing

Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients

Who this might be right for
Glioblastoma MultiformeHealthy Volunteers
University of Florida 130
Large-scale testing (Phase 3)Not Yet RecruitingNCT06477939
What this trial is testing

Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients

Who this might be right for
Glioblastoma
Institut de cancérologie Strasbourg Europe 554
Not applicableUnknownNCT02585219
What this trial is testing

Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas

Who this might be right for
Glioblastoma
University Medical Center Groningen 10
Early research (Phase 1)Study completedNCT02529072
What this trial is testing

Nivolumab With DC Vaccines for Recurrent Brain Tumors

Who this might be right for
Malignant GliomaAstrocytomaGlioblastoma
Gary Archer Ph.D. 6
Very early researchLooking for participantsNCT04135807
What this trial is testing

Implantable Microdevice In Primary Brain Tumors

Who this might be right for
Grade II GliomaGrade III GliomaGrade IV Glioma+5 more
Oliver Jonas 12
Not applicableStudy completedNCT05140902
What this trial is testing

Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom

Who this might be right for
Glioblastoma
University of Alabama at Birmingham 12
Early research (Phase 1)Active Not RecruitingNCT04808245
What this trial is testing

Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas

Who this might be right for
Newly Diagnosed H3-mutated Glioma
German Cancer Research Center 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899857
What this trial is testing

Pembrolizumab for Newly Diagnosed Glioblastoma

Who this might be right for
Newly Diagnosed Glioblastoma
University of Zurich 56
Testing effectiveness (Phase 2)Study completedNCT01854554
What this trial is testing

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 90
Early research (Phase 1)Active Not RecruitingNCT05533242
What this trial is testing

Radioimmunotherapy With Lu-177 Labeled 6A10 Fab-fragments in Patients With Glioblastoma After Standard Treatment

Who this might be right for
Glioblastom WHO Grade 4
University Hospital Muenster 10
Not applicableStudy completedNCT06451042
What this trial is testing

FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)

Who this might be right for
Glioblastoma Multiforme
Sunnybrook Health Sciences Centre 11
Early research (Phase 1)Looking for participantsNCT05366179
What this trial is testing

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

Who this might be right for
Glioblastoma Multiforme
UNC Lineberger Comprehensive Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT03047473
What this trial is testing

Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme of Brain
Clinique Neuro-Outaouais 38
Not applicableStudy completedNCT03481231
What this trial is testing

In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma

Who this might be right for
Glioblastoma
Centre Georges Francois Leclerc 160
Not applicableNot Yet RecruitingNCT06869577
What this trial is testing

A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma

Who this might be right for
CaregiverGlioblastoma Multiform (Grade IV Astrocytoma)
Rigshospitalet, Denmark 24
Early research (Phase 1)Study completedNCT04474353
What this trial is testing

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaNewly Diagnosed Glioblastoma
Stanford University 12
Early research (Phase 1)Study completedNCT00024557
What this trial is testing

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 40
Not applicableLooking for participantsNCT04699773
What this trial is testing

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

Who this might be right for
GliomaGlioblastomaBrain Tumor
University of Maryland, Baltimore 32
Next Page